John Overdeck’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
92,900
+33,139
+55% +$740K ﹤0.01% 3454
2026
Q1
$1.57M Buy
59,761
+17,297
+41% +$2.17M ﹤0.01% 2944
2025
Q4
$10.5M Buy
42,464
+13,873
+49% +$3.17M 0.01% 1085
2025
Q3
$6.02M Buy
28,591
+6,777
+31% +$1.2M 0.01% 1312
2025
Q2
$2.15M Buy
21,814
+5,871
+37% +$512K ﹤0.01% 1791
2025
Q1
$1.4M Buy
15,943
+4,802
+43% +$444K ﹤0.01% 1971
2024
Q4
$806K Buy
11,141
+3,254
+41% +$223K ﹤0.01% 2308
2024
Q3
$622K Buy
7,887
+4,012
+104% +$309K ﹤0.01% 2357
2024
Q2
$279K Sell
3,875
-6,235
-62% -$373K ﹤0.01% 2627
2024
Q1
$954K Sell
10,110
-2,668
-21% -$235K ﹤0.01% 1985
2023
Q4
$933K Buy
12,778
+6,077
+91% +$359K ﹤0.01% 2122
2023
Q3
$446K Sell
6,701
-12,916
-66% -$1.19M ﹤0.01% 2324
2023
Q2
$1.88M Sell
19,617
-3,824
-16% -$381K ﹤0.01% 1473
2023
Q1
$2.36M Buy
23,441
+5,152
+28% +$789K 0.01% 1279
2022
Q4
$3.17M Buy
18,289
+6,717
+58% +$4.42M 0.01% 1084
2022
Q3
$11.1M Buy
11,572
+8,502
+277% +$8.44M 0.04% 461
2022
Q2
$2.06M Sell
3,070
-2,543
-45% -$1.58M 0.01% 1190
2022
Q1
$3.9M Buy
5,613
+1,460
+35% +$1.13M 0.01% 1033
2021
Q4
$3.76M Buy
4,153
+1,786
+75% +$1.7M 0.01% 1387
2021
Q3
$2.38M Sell
2,367
-3,609
-60% -$2.66M 0.01% 1826
2021
Q2
$3.88M Sell
5,976
-2,750
-32% -$1.91M 0.01% 1349
2021
Q1
$6.46M Buy
8,726
+6,615
+313% +$5.34M 0.02% 913
2020
Q4
$1.63M Sell
2,111
-2,359
-53% -$1.86M ﹤0.01% 1624
2020
Q3
$4.44M Buy
4,470
+807
+22% +$856K 0.02% 855
2020
Q2
$3.81M Buy
3,663
+3,320
+968% +$3.34M 0.02% 772
2020
Q1
$279K Buy
+343
New +$358K ﹤0.01% 2374

Other funds holding GOSS

John Overdeck's GOSS Position: Q2 2026 in Review

John Overdeck increased its Gossamer Bio (GOSS) stake by 55% in Q2 2026, buying an estimated $740K and bringing the position to 92,900 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

John Overdeck first reported a position in GOSS in Q1 2020 and has held it in 26 quarters since. The position peaked at $11.1M in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • John Overdeck held 92,900 shares of Gossamer Bio worth $1.22M as of Q2 2026.
  • John Overdeck bought 33,139 Gossamer Bio shares in Q2 2026, an estimated $740K.
  • Gossamer Bio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3454 holding.
  • John Overdeck first reported a position in Gossamer Bio in Q1 2020 and has held it in 26 quarters since.
  • John Overdeck's Gossamer Bio position peaked at $11.1M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.